The FDA has approved Voluven (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, from Fresenius Kabi), an intravenous solution that prevents and treats a dangerous loss of blood volume, ...
WASHINGTON, Dec. 27 (UPI) -- The U.S. Food and Drug Administration has approved Voluven as a treatment for blood loss after surgery. Voluven is an intravenous solution that expands blood volume, the ...
Goal of the study: The third generation of unbalanced hydrxyethyl starch (HES) (130/04) (Voluven®) shows favorable physicochemical properties and avoids negative effects on coagulation Recently, ...
The U.S. Food and Drug Administration (FDA) has approved Voluven, an intravenous solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs during and after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback